Cargando…
Extended Use of the Wearable Cardioverter-Defibrillator: Which Patients Are Most Likely to Benefit?
BACKGROUND: Wearable cardioverter-defibrillators (WCD, LifeVest, ZOLL) can protect from sudden cardiac death bridging a vulnerable period until a decision on implantable cardioverter-defibrillator (ICD) implantation can be reached. WCD is commonly used for 3 months or less. It is unknown, which pati...
Autores principales: | Kovacs, Boldizsar, Reek, Sven, Krasniqi, Nazmi, Eriksson, Urs, Duru, Firat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304887/ https://www.ncbi.nlm.nih.gov/pubmed/30622822 http://dx.doi.org/10.1155/2018/7373610 |
Ejemplares similares
-
Wearable Cardioverter–Defibrillator-Measured Step Count for the Surveillance of Physical Fitness during Cardiac Rehabilitation
por: Kovacs, Boldizsar, et al.
Publicado: (2021) -
High Incidence of Inappropriate Alarms in Patients with Wearable Cardioverter-Defibrillators: Findings from the Swiss WCD Registry
por: Kovacs, Boldizsar, et al.
Publicado: (2021) -
Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry
por: El-Battrawy, Ibrahim, et al.
Publicado: (2022) -
Medical therapy with flecainide and propafenone in atrial fibrillation: Long-term clinical experience in the tertiary care setting
por: Kovacs, Boldizsar, et al.
Publicado: (2023) -
Wearable cardioverter defibrillator: A life vest till the life boat (ICD) arrives
por: Francis, Johnson, et al.
Publicado: (2014)